Champions oncology, inc. (CSBR)
Income statement / TTM
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10Jul'10
Oncology services revenue

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Oncology services revenue

-

0

0

-

-

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating revenue

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Personalized oncology solutions

-

-

-

-

-

-

-

-

-

-

-

15,411

1,940

2,009

1,998

1,972

1,804

1,841

1,807

1,663

1,675

1,812

1,983

2,264

2,375

2,258

2,094

2,390

2,342

2,518

2,649

2,332

2,406

3,176

2,874

3,382

0

0

0

Translational oncology solutions

-

-

-

-

-

-

-

-

-

-

-

-

12,589

11,507

10,032

9,210

9,781

9,021

7,966

7,200

6,405

8,129

8,459

9,286

8,560

7,904

7,143

5,933

5,517

4,820

4,972

4,817

4,909

4,548

4,042

3,500

0

0

0

Total operating revenue

-

-

-

-

-

-

-

-

-

-

-

15,411

14,529

13,516

12,030

11,182

11,585

10,862

9,773

8,863

8,080

9,941

10,442

11,550

10,935

10,162

9,237

8,323

7,859

7,338

7,621

7,149

7,315

7,724

6,916

6,882

0

0

0

Costs and operating expenses:
Cost of oncology services

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of oncology services

-

-

-

-

-

-

-

-

-

-

-

9,703

1,562

1,721

1,915

2,102

2,251

2,446

2,637

2,733

2,782

2,722

2,695

2,731

2,781

2,843

2,693

2,672

2,914

2,766

2,645

2,356

1,924

2,121

1,824

1,665

0

0

0

Cost of translational oncology solutions

-

-

-

-

-

-

-

-

-

-

-

-

7,866

7,407

7,021

6,584

6,356

6,030

5,547

4,900

4,174

3,881

3,619

3,532

3,500

3,058

2,835

2,656

2,443

2,678

2,823

2,543

2,381

2,268

2,043

1,846

0

0

0

Research and development

5,283

5,161

5,013

4,798

4,673

4,449

4,371

4,401

4,354

4,307

4,200

4,293

4,393

4,394

4,305

4,194

4,098

4,192

4,522

4,845

4,416

3,858

3,286

2,265

2,119

2,176

1,935

1,920

1,873

2,211

2,783

2,937

3,363

2,867

2,532

2,910

0

0

0

Sales and marketing

4,073

3,645

3,408

3,056

2,846

2,594

2,405

2,570

2,754

2,853

3,019

3,261

3,171

3,224

3,341

3,445

3,594

3,909

4,278

4,283

4,325

4,052

3,547

3,155

2,779

2,616

2,598

2,665

3,013

2,978

2,949

2,928

2,594

2,210

1,639

1,085

0

0

0

General and administrative

5,483

5,150

5,049

4,678

4,216

3,997

3,917

4,071

4,738

4,570

4,638

4,963

4,507

4,712

5,390

5,173

5,473

5,518

5,195

5,340

5,582

6,616

6,518

6,127

5,617

4,642

4,564

4,631

4,460

4,602

4,871

5,450

6,340

6,558

5,724

4,611

0

0

0

Total costs and operating expenses

31,099

29,320

28,404

26,797

24,483

22,832

21,687

21,595

22,185

22,002

21,679

22,220

21,499

21,458

21,972

21,498

21,772

22,095

22,179

22,101

21,279

21,129

19,665

17,810

16,796

15,335

14,625

14,544

14,703

15,235

16,071

16,214

16,602

16,024

13,762

12,117

0

0

0

Income (loss) from operations

-6

-809

-825

270

-212

91

-254

-1,354

-3,148

-4,482

-4,905

-6,809

-6,970

-7,942

-9,942

-10,316

-10,187

-11,233

-12,406

-13,238

-13,199

-11,188

-9,223

-6,260

-5,861

-5,173

-5,388

-6,221

-6,844

-7,897

-8,450

-9,065

-9,287

-8,300

-6,846

-5,235

0

0

0

Other income (expense):
Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

981

1,637

1,862

652

-965

-1,253

-2,354

-1,821

-74

42

363

525

417

317

251

141

-36

0

0

0

Other income (expense)

-33

-18

-52

-39

-23

-31

-37

-89

-94

-95

-98

-56

-39

-39

-37

-38

-200

-198

-211

-170

-129

-130

-132

-164

-41

-44

-20

-25

-33

0

0

-

0

-

-

-

-

-

-

Other (expense) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

3

15

0

0

0

Total other expense (income)

-

-

-52

-

-

-

-37

-89

-94

-95

-98

-56

-39

-39

-37

-38

-1,206

-583

29

225

1,508

1,732

520

-1,129

-1,294

-2,398

-1,841

-99

8

327

504

402

451

768

1,609

1,444

0

0

0

Income (loss) before provision for income taxes

-39

-827

-877

231

-235

60

-291

-1,443

-3,242

-4,577

-5,003

-6,865

-7,009

-7,981

-9,979

-10,354

-11,393

-11,816

-12,377

-13,013

-11,691

-9,456

-8,703

-7,389

-7,155

-7,571

-7,229

-6,320

-6,836

-7,570

-7,946

-8,663

-8,836

-7,532

-5,237

-3,791

0

0

0

Income Tax Expense (Benefit)

140

128

118

103

17

19

29

33

27

25

9

19

23

54

100

92

178

159

128

127

33

26

19

17

12

12

10

10

9

0

0

-

0

-

11

11

0

0

0

Provision for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-179

-955

-995

128

-252

41

-320

-1,476

-3,268

-4,601

-5,011

-6,884

-7,031

-8,034

-10,078

-10,445

-11,571

-11,974

-12,504

-13,139

-11,724

-9,482

-8,722

-7,406

-7,167

-7,583

-7,239

-6,330

-6,843

-7,572

-7,947

-8,661

-8,847

-7,543

-5,248

-3,802

0

0

0

Net income (loss) per common share outstanding
Net loss per common share outstanding, basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-0.20

-0.13

-0.05

-0.26

-0.30

-0.28

-0.29

-0.33

-

-

-

-

-

-

-

-0.03

-0.03

-0.02

-0.04

-0.03

-0.06

-0.04

-0.05

-0.04

-0.08

-0.01

0.00

-0.02

Net income (loss) per common share outstanding, basic (in dollars per share)

0.03

0.03

-0.06

-0.02

-0.03

0.02

0.04

-0.05

-0.01

-0.01

-0.06

-

-

-

-

-

-

-

-

-

-0.51

-0.05

-0.64

-

-0.01

-0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per common share outstanding, diluted (in dollars per share)

0.03

0.02

-0.06

-0.02

-0.03

0.02

0.04

-0.05

-0.01

-0.01

-0.06

-

-

-

-

-

-

-

-

-

-0.61

-0.05

-0.64

-

-0.02

-0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding
Weighted average common shares outstanding, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

10,967

10,967

10,967

9,835

8,674

8,702

8,702

8,702

-

-

-

-

-

-

-

66,852,100

-93,985,549

47,737

47,079,000

47,067,000

47,312

46,738

46,790

46,420

-

-

-

-

Weighted average common shares outstanding, basic (in shares)

11,752

11,619

11,619

11,561

11,508

11,278

11,012

10,999

10,994

10,988

10,982

-

-

-

-

-

-

-

-

-

5,574

66,887

5,573

-

66,867

66,863

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, diluted (in shares)

13,673

12,964

11,619

18,221

11,508

14,037

12,618

10,999

10,994

10,988

10,982

-

-

-

-

-

-

-

-

-

5,603

67,855

5,819

-

66,867

66,863

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding, including redeemable common stock, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,664

-

-

Weighted average common shares outstanding, including redeemable common stock, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0